RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

My bet is that corx gets approached with buy-out offers regularly, but at this share-price, they are reluctant to sell. They lack the funds to get the kind of data that would attract the kind of partnerships that would boost share-price.

Maybe a semi-buyout would work: sell all the low-impacts at ~60% of the going buyout price, then focus on the high-impacts. They need to buy 2-5 years of operating expenses.